P76.03 Efficacy and Safety of Capmatinib Plus Nivolumab in Pretreated Patients with EGFR Wild-Type Non–Small Cell Lung Cancer
2021
-
Correction
-
Source
-
Cite
-
Save
0
References
1
Citations
NaN
KQI